Tyler Marciniak

Investor Relations Kontakt på TRANSCENTA HOLDING LIMITED

Health Technology

Consumer Services

Profil

Tyler Marciniak is SVP-Investor Relations & Corporate Communications at Transcenta Holding Ltd. since 2025.
Former roles include Director-Oncology Communications & Advocacy at Astellas Pharma, Inc. and VP-Investor Relations, Media & Operation at ACELYRIN, Inc. Education includes graduate studies at The Trustees of Columbia University in The City of New York and an MBA from Kellogg School of Management.

Aktiva positioner av Tyler Marciniak

Företag	Position	Start
TRANSCENTA HOLDING LIMITED	Investor Relations Kontakt	2025-10-16

Alla aktiva positioner av Tyler Marciniak

Tidigare kända positioner av Tyler Marciniak

Företag	Position	Slut
ACELYRIN, INC.	Investor Relations Kontakt	2025-05-21
ASTELLAS PHARMA INC.	Företagsledare/Principal	-

Se detaljerna i Tyler Marciniaks erfarenhet

Tyler Marciniaks utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Tyler Marciniaks erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Astellas Pharma, Inc. Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products	Health Technology
Kellogg School of Management Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Transcenta Holding Ltd. Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products	Health Technology
ACELYRIN, Inc. ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines	Health Technology